trial

A Placebo-Controlled, Cross-Over Trial of Aripiprazole

NCTId NCT00351936
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 16 (actual)
Sponsored by North Suffolk Mental Health Association
Primary completion 2007-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
16 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Quadruple
Start
2005-12
Primary completion
2007-07
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Aripiprazole

Sponsors

North Suffolk Mental Health AssociationLead Sponsor
Eli Lilly and CompanyCollaborator

Investigators

1
David C. Henderson, MDPrincipal Investigator

Sites

1 total
Boston, United States

Facts & assertions

4 sourced
Enrollment
16
Phase
PHASE4
Primary Completion Date
2007-07
Status
COMPLETED
relationships
The graph out of here
drug
Aripiprazole
drug
lead_sponsor
North Suffolk Mental Health Association
company
collaborator
Eli Lilly and Company
company
indication
Insulin Resistance
indication
Obesity
indication
Diabetes Mellitus
indication
investigator
David C. Henderson, MD
person